The ATS Foundation, Coalition for Pulmonary Fibrosis, and the Pulmonary Fibrosis Foundation Award $100,000 to Chi Hung, MD to Study Idiopathic Pulmonary Fibrosis. CULVER CITY, Calif., Jan. 10, 2014 (GLOBE NEWSWIRE) -- The ATS Foundation, Coalition for Pulmonary Fibrosis, and the Pulmonary Fibrosis Foundation have awarded $100,000 to Chi Hung, MD, a Clinical...

Month-long Efforts Boost Little Known Disease that Claims as Many Lives as Breast Cancer WASHINGTON, Oct. 3, 2013 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) proclaimed its month-long efforts for awareness during September a success with important highlights such as a...

Pulmonary Fibrosis Patients, Advocacy Groups Applaud FDA Decision to Add Untreatable Lung Disease as Part of Five-Year Patient-Focused Drug Development Program CULVER CITY, Calif., April 16, 2013 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) and the Pulmonary Fibrosis Foundation (PFF) today applaud the FDA for including Idiopathic Pulmonary...